Cargando…
Azithromycin promotes proliferation, and inhibits inflammation in nasal epithelial cells in primary ciliary dyskinesia
Primary ciliary dyskinesia (PCD) is a genetic disorder associated with recurrent and chronic respiratory infections due to functional defects of motile cilia. In this study, we aimed to elucidate inflammatory and proliferative responses in PCD respiratory epithelium and evaluate the effect of Azithr...
Autores principales: | Varenyiova, Zofia, Rojas-Hernandez, Laura S., Spano, Jacquelyn, Capek, Vaclav, Rosenberg-Hasson, Yael, Holmes, Tyson, Milla, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475097/ https://www.ncbi.nlm.nih.gov/pubmed/37660113 http://dx.doi.org/10.1038/s41598-023-41577-5 |
Ejemplares similares
-
Evaluation of a Clinical Index as a Predictive Tool for Primary Ciliary Dyskinesia
por: Martinů, Vendula, et al.
Publicado: (2021) -
Long-Term Azithromycin Treatment in Pediatric Primary Ciliary Dyskinesia: A Retrospective Study
por: Guan, Yuhong, et al.
Publicado: (2022) -
Limitations of Nasal Nitric Oxide Testing in Primary Ciliary Dyskinesia
por: Shapiro, Adam J., et al.
Publicado: (2020) -
Domiciliary High-Flow Nasal Therapy in Primary Ciliary Dyskinesia
por: Gomes, Rita, et al.
Publicado: (2023) -
Nasal Nitric Oxide Levels: Improving the Diagnosis of Primary Ciliary Dyskinesia in Puerto Rico
por: De Jesús-Rojas, Wilfredo, et al.
Publicado: (2022)